From the *Department of Cardiovascular Surgery Tokyo Women’s Medical University, Tokyo, Japan
†Department of Cardiology, Tokyo Women’s Medical University, Tokyo, Japan
‡Department of therapeutic strategy for heart failure, Tokyo Women’s Medical University, Tokyo, Japan
§Department of surgical pathology, Tokyo Women’s Medical University, Tokyo, Japan.
Submitted for consideration September 2021; accepted for publication in revised form June 2022.
Disclosure: The authors declare that they have no conflicts of interest.
All procedure performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Correspondence: Yukiko Yamada, MD, PhD, Department of Cardiovascular Surgery, Tokyo Women’s Medical University 8-1 Kawata-cho, Shinjulu-ku, Tokyo 162-8666, Japan. E-mail: [email protected]
